Biomed Central Ltd

SHERPA: Unknown

People

  1. Budhu
    Budhu
  2. Cheung
    Cheung
  3. Liu
    Liu
  4. Zhong
    Zhong
  5. De Stanchina
    De Stanchina
  6. Deng
    Deng
  7. Guo
    Guo
  8. Hadjantonakis
    Hadjantonakis
  9. Hirschhorn Cymerman
    Hirschhorn Cymerman
  10. Nowotschin
    Nowotschin

Groups

  1. Sloan Kettering Institute Postdocs (193)
  2. GSK Faculty (115)
  3. Department of Medicine (89)
  4. Solid Tumor Oncology Division (75)
  5. Melanoma and Immunotherapeutics Service (51)
  6. Sloan Kettering Institute Faculty (49)
  7. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (37)
  8. Epidemiology and Biostatistics (37)
  9. Tow Center for Developmental Oncology (TCDO) (35)
  10. Center for Molecular Imaging and Biotechnology (32)
Search Within
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (116)
  2. Meeting Abstract (63)
  3. Review (9)
  4. Research Letter (2)
  5. Conference Paper (1)
  6. Editorial (1)
  7. Guidelines (1)
Groups
  1. Sloan Kettering Institute Postdocs (193)
  2. GSK Faculty (115)
  3. Department of Medicine (89)
  4. Solid Tumor Oncology Division (75)
  5. Melanoma and Immunotherapeutics Service (51)
  6. Sloan Kettering Institute Faculty (49)

More Groups

People
  1. Taha Merghoub (45)
  2. Jedd Wolchok (43)
  3. Roberta Zappasodi (24)
  4. Sadna Budhu (22)
  5. Levi Mark Mangarin (11)
  6. Cailian Liu (10)

More People

Years
  1. 2025 (6)
  2. 2024 (11)
  3. 2023 (12)
  4. 2022 (27)
  5. 2021 (20)
  6. 2020 (22)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (86)
  2. Breast Cancer Research (12)
  3. BMC Bioinformatics (11)
  4. Genome Medicine (10)
  5. Journal of Hematology & Oncology (10)
  6. Genome Biology (9)

More Publications

Results (193)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells
    Journal Article

    Fucà, G.; Ambrosini, M.; Agnelli, L.; Brich, S.; Sgambelluri, F.; Mortarini, R.; Pupa, S. M.; Magni, M.; Devizzi, L.; Matteucci, P.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia
    Journal Article

    Hoseini, S. S.; Vadlamudi, M.; Espinosa-Cotton, M.; Tran, H.; Feng, Y.; Guo, H. F.; Xu, H.; Cheung, I.; Cheung, N. K. V.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
    Journal Article

    Tsui, D. W. Y.; Cheng, M. L.; Shady, M.; Yang, J. L.; Stephens, D.; Won, H.; Srinivasan, P.; Huberman, K.; Meng, F.; Jing, X.; more...
    Genome Medicine (2021)

    Fulltext@MSK | Save
  • Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release
    Journal Article

    Park, J. A.; Santich, B. H.; Xu, H.; Lum, L. G.; Cheung, N. K. V.
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
    Journal Article

    Askan, G.; Sahin, I. H.; Chou, J. F.; Yavas, A.; Capanu, M.; Iacobuzio-Donahue, C. A.; Basturk, O.; O’Reilly, E. M.
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
    Review

    Lumish, M.; Falchi, L.; Imber, B. S.; Scordo, M.; von Keudell, G.; Joffe, E.
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Tired and hungry: A potential role for CD47 in T cell exhaustion
    Meeting Abstract

    Mangarin, L.; Liu, C.; Zappasodi, R.; Holland, P.; Wolchok, J.; Merghoub, T.; Weng, C. H.; Weng, C. H.; Schroder, D.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Characterizing double positive T cells in the tumor microenvironment: A tale of promiscuous cell fates
    Meeting Abstract

    Schad, S.; Chow, A.; Pan, H.; Mangarin, L.; Zappasodi, R.; Gigoux, M.; Redmond, D.; Hirschhorn-Cymerman, D.; Budhu, S.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
    Meeting Abstract

    Gigoux, M.; Zappasodi, R.; Park, J.; Pourpe, S.; Ghosh, A.; Bozkus, C. C.; Mangarin, L.; Redmond, D.; Verma, S.; Schad, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save